Business US

Leucovorin, Jeffrey Epstein, Novo, FDA: Readout Newsletter

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. We’ve got a lot of news and deep dives today, so let’s get straight to it.

A top VC helped Epstein’s friend make a comeback

The biotech industry appeared to distance itself from investor Boris Nikolic after his friendship with Jeffrey Epstein came to light in 2019. But in the following years, one of the most influential biotech venture capitalists, Alexis Borisy, quietly shepherded a comeback for Nikolic, my colleague Damian Garde reports in a new exclusive.

STAT+ Exclusive Story

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

Individual plans

Group plans

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button